Page 335 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 335

TC-20


               Investigation of the commercial bupleuri radix by microscopic morphology

               and saikosaponins analysis


                                                                                 1
                                               1
                              1
               Ying-Min Lai,  Chen-Pei Chiu,  Shih-Yun Chang,  Li-Jie Zhang,  Chia-Ching Liaw*       ,1,2,3,4
                                                                  1

               1  National Research Institute of Chinese Medicine, MOHW, Taipei 112, Taiwan.
               2  Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 807,
                 Taiwan
               3  Department of Pharmacy, School of Pharmaceutical Sciences, National Yang Ming Chiao
                 Tung University, Taipei 112, Taiwan
               4  Department of Biochemical Science and Technology, National Chiayi University, Chiayi,
                 600, Taiwan
               * E-mail: liawcc@nricm.edu.tw

               Abstract
                  Bupleuri Radix (Chaihu), first documented in the Mingyi Bielu, has traditionally been used
               to relieve fever, alleviate pain, detoxify, and reduce inflammation. Clinically, it is prescribed
               for conditions such as the common cold, cough, hepatitis, and hyperlipidemia. According to the
                                                                  th
               revised notice of the Taiwan Herbal Pharmacopeia (4  edition, 2025/07/30), the medicinal part
               was updated from the dried root of Bupleurum chinense DC. or B. scorzonerifolium Willd. to
               include both the dried root and rhizome. To investigate the usage and quality of Bupleuri Radix
               in Taiwan, 12 commercial samples were collected from herbal stores across northern, central,
               and southern regions. Appearance inspection and microscopic identification confirmed that all
               samples originated from B. chinense DC., with no evidence of B. scorzonerifolium Willd. The
               proportion of rhizome in the material ranged from 9.7% to 39.2%. Quantitative analysis of
               saikosaponins (A, C, and D) revealed the content range of 0.45%–5.31%, with ten samples
               meeting  the  THP-IV  requirement  (>0.8%).  Notably,  some  samples  with  lighter-colored
               periderm exhibited higher saikosaponins levels, exceeding 5%. Although the HPLC fingerprints
               of root and rhizome were highly similar, the saikosaponins content of the root (0.52%–6.76%)
               was  approximately  1.5–2.5  folds  higher  than  that  of  the  rhizome  (0.21%–4.49%).  Further
               research in the different part from the material demonstrated that saikosaponins were mainly
               distributed in the non-xylem tissues.

               Keywords: Bupleuri Radix; Bupleurum chinense DC; Saikosaponins; Microscopic morphology
   330   331   332   333   334   335   336   337   338   339   340